Cargando…
Decreased Metabolism in the Cerebral Cortex in Early-Stage Huntington's Disease: A Possible Biomarker of Disease Progression?
BACKGROUND AND PURPOSE: Huntington's disease (HD) is an autosomal-dominant inherited neurodegenerative disorder. Genetic analysis of abnormal CAG expansion in the IT15 gene allows disease confirmation even in the preclinical stage. However, because there is no treatment to cure or delay the pro...
Autores principales: | Shin, Hyeeun, Kim, Man Ho, Lee, Su Jin, Lee, Kyung-Han, Kim, Mi-Jung, Kim, Ji Sun, Cho, Jin Whan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543905/ https://www.ncbi.nlm.nih.gov/pubmed/23346156 http://dx.doi.org/10.3988/jcn.2013.9.1.21 |
Ejemplares similares
-
Role of cerebral cortex in the neuropathology of Huntington's disease
por: Estrada-Sánchez, Ana M., et al.
Publicado: (2013) -
Preliminary Study of Intravenous Amantadine Treatment for Ataxia Management in Patients with Probable Multiple System Atrophy with Predominant Cerebellar Ataxia
por: Youn, Jinyoung, et al.
Publicado: (2012) -
Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020) -
Quantitative Gait Analysis in Patients with Huntington’s Disease
por: Pyo, Seon Jong, et al.
Publicado: (2017) -
Comprehensive shape analysis of the cortex in Huntington's disease
por: Stoebner, Zachary A., et al.
Publicado: (2022)